Epigenetic silencing of transposable elements by IRF2BP2 is a selective dependency of myeloid leukemia
Authors:
- Jingru XuJXJingru Xu
- Jessica WhittleJWJessica Whittle
- Liam ClayfieldLCLiam Clayfield
- Michael Lie-A-LingMLMichael Lie-A-Ling
- Eve Augusta LeddyELEve Augusta Leddy
- Duncan SmithDSDuncan Smith
- Robert SellersRSRobert Sellers
- Ozgen DenizODOzgen Deniz
- Georges LacaudGLGeorges Lacaud
Preprint
Abstract
Acute myeloid leukemia (AML) is a heterogeneous malignancy with limited curative treatment options. Transposable elements (TEs) are now recognized as key regulators of genome function, with aberrant activation implicated in cancer. However, their tumor-type-specific roles remain poorly characterized. Using single-cell Perturb-seq, we systematically screened for chromatin-associated regulators in primary AML patient cells to uncover dependencies required for leukemia cell viability. Our screen identified IRF2BP2 as an AML-selective dependency, functioning as a repressor of TE expression. Loss of IRF2BP2 induced differentiation, apoptosis, and impaired leukemic cell fitness, phenotypes linked to transcriptional activation of TEs, particularly evolutionarily young human endogenous retrovirus K (HERV-K). Mechanistically, IRF2BP2 cooperates with TRIM28 and DNMT1 to epigenetically silence TE expression. CRISPR-mediated activation of HERV-K/LTR5_Hs recapitulated the phenotypic effects of IRF2BP2 loss, while targeted re-silencing of HERV-K/LTR5_Hs partially rescued the effects, establishing a causal link between TE regulation and AML maintenance. Our findings highlight tumor-suppressive functions of TEs in leukemia and reveal IRF2BP2 as a key regulator of TE silencing in AML. Targeting the epigenetic machinery governing TE repression may represent a promising therapeutic avenue for differentiation-inducing and immunomodulatory strategies in AML.Keywords
This publication has 61 references indexed in Scilit:
- Endogenous retroelements as alarms for disruptions to cellular homeostasisTrends in Cancer, 2022
- IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signalingThe Journal of Steroid Biochemistry and Molecular Biology, 2019
- TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human PluripotencyStem Cell Reports, 2018
- Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic ScreensCell, 2016
- Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorderJournal of Allergy and Clinical Immunology, 2016
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesCell, 2015
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsCell, 2015
- TRIM28 Represses Transcription of Endogenous Retroviruses in Neural Progenitor CellsCell Reports, 2015
- In Embryonic Stem Cells, ZFP57/KAP1 Recognize a Methylated Hexanucleotide to Affect Chromatin and DNA Methylation of Imprinting Control RegionsMolecular Cell, 2011
- Characterization and Analysis of Posttranslational Modifications of the Human Large Cytoplasmic Ribosomal Subunit Proteins by Mass Spectrometry and Edman SequencingThe Protein Journal, 2003